Literature DB >> 17015455

Mutation of the maturase lipoprotein attenuates the virulence of Streptococcus equi to a greater extent than does loss of general lipoprotein lipidation.

Andrea Hamilton1, Carl Robinson, Iain C Sutcliffe, Josh Slater, Duncan J Maskell, Nick Davis-Poynter, Ken Smith, Andrew Waller, Dean J Harrington.   

Abstract

Streptococcus equi is the causative agent of strangles, a prevalent and highly contagious disease of horses. Despite the animal suffering and economic burden associated with strangles, little is known about the molecular basis of S. equi virulence. Here we have investigated the contributions of a specific lipoprotein and the general lipoprotein processing pathway to the abilities of S. equi to colonize equine epithelial tissues in vitro and to cause disease in both a mouse model and the natural host in vivo. Colonization of air interface organ cultures after they were inoculated with a mutant strain deficient in the maturase lipoprotein (DeltaprtM(138-213), with a deletion of nucleotides 138 to 213) was significantly less than that for cultures infected with wild-type S. equi strain 4047 or a mutant strain that was unable to lipidate preprolipoproteins (Deltalgt(190-685)). Moreover, mucus production was significantly greater in both wild-type-infected and Deltalgt(190-685)-infected organ cultures. Both mutants were significantly attenuated compared with the wild-type strain in a mouse model of strangles, although 2 of 30 mice infected with the Deltalgt(190-685) mutant did still exhibit signs of disease. In contrast, only the DeltaprtM(138-213) mutant was significantly attenuated in a pony infection study, with 0 of 5 infected ponies exhibiting pathological signs of strangles compared with 4 of 4 infected with the wild-type and 3 of 5 infected with the Deltalgt(190-685) mutant. We believe that this is the first study to evaluate the contribution of lipoproteins to the virulence of a gram-positive pathogen in its natural host. These data suggest that the PrtM lipoprotein is a potential vaccine candidate, and further investigation of its activity and its substrate(s) are warranted.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17015455      PMCID: PMC1698103          DOI: 10.1128/IAI.01116-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  59 in total

1.  The potential active site of the lipoprotein-specific (type II) signal peptidase of Bacillus subtilis.

Authors:  H Tjalsma; G Zanen; G Venema; S Bron; J M van Dijl
Journal:  J Biol Chem       Date:  1999-10-01       Impact factor: 5.157

2.  The putative proteinase maturation protein A of Streptococcus pneumoniae is a conserved surface protein with potential to elicit protective immune responses.

Authors:  K Overweg; A Kerr; M Sluijter; M H Jackson; T J Mitchell; A P de Jong; R de Groot; P W Hermans
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

3.  Lipid modification of prelipoproteins is dispensable for growth in vitro but essential for virulence in Streptococcus pneumoniae.

Authors:  C M Petit; J R Brown; K Ingraham; A P Bryant; D J Holmes
Journal:  FEMS Microbiol Lett       Date:  2001-06-25       Impact factor: 2.742

4.  Recombinant hyaluronate associated protein as a protective immunogen against Streptococcus equi and Streptococcus zooepidemicus challenge in mice.

Authors:  N Chanter; C L Ward; N C Talbot; J A Flanagan; M Binns; S B Houghton; K C Smith; J A Mumford
Journal:  Microb Pathog       Date:  1999-09       Impact factor: 3.738

5.  Identification of lipoprotein homologues of pneumococcal PsaA in the equine pathogens Streptococcus equi and Streptococcus zooepidemicus.

Authors:  D J Harrington; J S Greated; N Chanter; I C Sutcliffe
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

6.  Characterization of acid phosphatase activities in the equine pathogen Streptococcus equi.

Authors:  A Hamilton; D Harrington; I C Sutcliffe
Journal:  Syst Appl Microbiol       Date:  2000-10       Impact factor: 4.022

7.  Lipid modification of prelipoproteins is dispensable for growth but essential for efficient protein secretion in Bacillus subtilis: characterization of the Lgt gene.

Authors:  S Leskelä; E Wahlström; V P Kontinen; M Sarvas
Journal:  Mol Microbiol       Date:  1999-02       Impact factor: 3.501

8.  Complete genome sequence of a virulent isolate of Streptococcus pneumoniae.

Authors:  H Tettelin; K E Nelson; I T Paulsen; J A Eisen; T D Read; S Peterson; J Heidelberg; R T DeBoy; D H Haft; R J Dodson; A S Durkin; M Gwinn; J F Kolonay; W C Nelson; J D Peterson; L A Umayam; O White; S L Salzberg; M R Lewis; D Radune; E Holtzapple; H Khouri; A M Wolf; T R Utterback; C L Hansen; L A McDonald; T V Feldblyum; S Angiuoli; T Dickinson; E K Hickey; I E Holt; B J Loftus; F Yang; H O Smith; J C Venter; B A Dougherty; D A Morrison; S K Hollingshead; C M Fraser
Journal:  Science       Date:  2001-07-20       Impact factor: 47.728

9.  Quantitation of the capacity of the secretion apparatus and requirement for PrsA in growth and secretion of alpha-amylase in Bacillus subtilis.

Authors:  M Vitikainen; T Pummi; U Airaksinen; E Wahlström; H Wu; M Sarvas; V P Kontinen
Journal:  J Bacteriol       Date:  2001-03       Impact factor: 3.490

10.  Characterization of an HPr kinase mutant of Staphylococcus xylosus.

Authors:  P L Huynh; I Jankovic; N F Schnell; R Brückner
Journal:  J Bacteriol       Date:  2000-04       Impact factor: 3.490

View more
  24 in total

1.  Phosphatidylglycerol::prolipoprotein diacylglyceryl transferase (Lgt) of Escherichia coli has seven transmembrane segments, and its essential residues are embedded in the membrane.

Authors:  Jérémy Pailler; Willy Aucher; Magali Pires; Nienke Buddelmeijer
Journal:  J Bacteriol       Date:  2012-01-27       Impact factor: 3.490

Review 2.  Lipoproteins of bacterial pathogens.

Authors:  A Kovacs-Simon; R W Titball; S L Michell
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

Review 3.  Lipoproteins of Gram-Positive Bacteria: Key Players in the Immune Response and Virulence.

Authors:  Minh Thu Nguyen; Friedrich Götz
Journal:  Microbiol Mol Biol Rev       Date:  2016-08-10       Impact factor: 11.056

4.  Determinants of Genetic Diversity of Spontaneous Drug Resistance in Bacteria.

Authors:  Alejandro Couce; Alexandro Rodríguez-Rojas; Jesús Blázquez
Journal:  Genetics       Date:  2016-05-10       Impact factor: 4.562

5.  Prominent Binding of Human and Equine Fibrinogen to Streptococcus equi subsp. zooepidemicus Is Mediated by Specific SzM Types and Is a Distinct Phenotype of Zoonotic Isolates.

Authors:  René Bergmann; Maria-Christin Jentsch; Albrecht Uhlig; Uwe Müller; Mark van der Linden; Magnus Rasmussen; Andrew Waller; Maren von Köckritz-Blickwede; Christoph Georg Baums
Journal:  Infect Immun       Date:  2019-12-17       Impact factor: 3.441

6.  NisI Maturation and Its Influence on Nisin Resistance in Lactococcus lactis.

Authors:  Jiaheng Liu; Hui Xiong; Yuhui Du; Itsanun Wiwatanaratanabutr; Xiaofang Wu; Guangrong Zhao; Hongji Zhu; Qinggele Caiyin; Jianjun Qiao
Journal:  Appl Environ Microbiol       Date:  2020-09-17       Impact factor: 4.792

7.  Contribution of each of four Superantigens to Streptococcus equi-induced mitogenicity, gamma interferon synthesis, and immunity.

Authors:  Romain Paillot; Carl Robinson; Karen Steward; Nicola Wright; Thibaud Jourdan; Nicola Butcher; Zoe Heather; Andrew S Waller
Journal:  Infect Immun       Date:  2010-02-01       Impact factor: 3.441

8.  Contribution of lipoproteins and lipoprotein processing to endocarditis virulence in Streptococcus sanguinis.

Authors:  Sankar Das; Taisei Kanamoto; Xiuchun Ge; Ping Xu; Takeshi Unoki; Cindy L Munro; Todd Kitten
Journal:  J Bacteriol       Date:  2009-04-24       Impact factor: 3.490

9.  Involvement of peptidylprolyl cis/trans isomerases in Enterococcus faecalis virulence.

Authors:  Fany Reffuveille; Nathalie Connil; Maurizio Sanguinetti; Brunella Posteraro; Sylvie Chevalier; Yanick Auffray; Alain Rince
Journal:  Infect Immun       Date:  2012-02-13       Impact factor: 3.441

10.  Getting to grips with strangles: an effective multi-component recombinant vaccine for the protection of horses from Streptococcus equi infection.

Authors:  Bengt Guss; Margareta Flock; Lars Frykberg; Andrew S Waller; Carl Robinson; Ken C Smith; Jan-Ingmar Flock
Journal:  PLoS Pathog       Date:  2009-09-18       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.